{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:12:38Z","timestamp":1779127958269,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11886-019-1239-0","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T09:05:36Z","timestamp":1574672736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MitraClip: How Do We Reconcile the Inconsistent Findings of MITRA-FR and COAPT?"],"prefix":"10.1007","volume":"21","author":[{"given":"Rina","family":"Mauricio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharam J.","family":"Kumbhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"1239_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1540-8191.2011.01274.x","volume":"26","author":"E de Marchena","year":"2011","unstructured":"de Marchena E, Badiye A, Robalino G, Junttila J, Atapattu S, Nakamura M, et al. Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development. J Card Surg. 2011;26:385\u201392.","journal-title":"J Card Surg"},{"key":"1239_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jcmg.2018.01.009","volume":"11","author":"A El Sabbagh","year":"2018","unstructured":"El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. J Am Coll Cardiol Img. 2018;11:628\u201343.","journal-title":"J Am Coll Cardiol Img"},{"key":"1239_CR3","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/01.CIR.96.6.1826","volume":"96","author":"S He","year":"1997","unstructured":"He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation. 1997;96:1826\u201334.","journal-title":"Circulation."},{"key":"1239_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.euje.2004.03.001","volume":"5","author":"E Agricola","year":"2004","unstructured":"Agricola E, Oppizzi M, Maisano F, De Bonis M, Schinkel AF, Torracca L, et al. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr. 2004;5:326\u201334.","journal-title":"Eur J Echocardiogr"},{"key":"1239_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/eurjhf\/hfp051","volume":"11","author":"E Agricola","year":"2009","unstructured":"Agricola E, Ielasi A, Oppizzi M, Faggiano P, Ferri L, Calabrese A, et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail. 2009;11:581\u20137.","journal-title":"Eur J Heart Fail"},{"key":"1239_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jacc.2004.10.030","volume":"45","author":"F Grigioni","year":"2005","unstructured":"Grigioni F, Detaint D, Avierinos JF, Scott C, Tajik J, Enriquez-Sarano M. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol. 2005;45:260\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1239_CR7","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","volume":"103","author":"F Grigioni","year":"2001","unstructured":"Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759\u201364.","journal-title":"Circulation."},{"key":"1239_CR8","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","volume":"97","author":"A Rossi","year":"2011","unstructured":"Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97:1675\u201380.","journal-title":"Heart."},{"key":"1239_CR9","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","volume":"135","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159\u201395.","journal-title":"Circulation."},{"key":"1239_CR10","first-page":"e521","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521\u2013643.","journal-title":"Circulation."},{"key":"1239_CR11","doi-asserted-by":"crossref","unstructured":"Dargie H J, Lechat P. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"1239_CR12","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651\u20138.","journal-title":"N Engl J Med"},{"key":"1239_CR13","doi-asserted-by":"crossref","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001\u20137.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"1239_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349\u201355.","journal-title":"N Engl J Med"},{"key":"1239_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004.","journal-title":"N Engl J Med"},{"key":"1239_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JG Cleland","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539\u201349.","journal-title":"N Engl J Med"},{"key":"1239_CR17","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140\u201350.","journal-title":"N Engl J Med"},{"key":"1239_CR18","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","volume":"346","author":"WT Abraham","year":"2002","unstructured":"Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845\u201353.","journal-title":"N Engl J Med"},{"key":"1239_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"AJ Moss","year":"2009","unstructured":"Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329\u201338.","journal-title":"N Engl J Med"},{"key":"1239_CR20","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","volume":"363","author":"AS Tang","year":"2010","unstructured":"Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385\u201395.","journal-title":"N Engl J Med"},{"key":"1239_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"1239_CR22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395\u2013406.","journal-title":"N Engl J Med"},{"key":"1239_CR23","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.jacc.2015.10.018","volume":"66","author":"T Feldman","year":"2015","unstructured":"Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66:2844\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"1239_CR24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/eurjhf\/hfs079","volume":"14","author":"S Baldus","year":"2012","unstructured":"Baldus S, Schillinger W, Franzen O, Bekeredjian R, Sievert H, Schofer J, et al. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2012;14:1050\u20135.","journal-title":"Eur J Heart Fail"},{"key":"1239_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/eurheartj\/ehv627","volume":"37","author":"M Puls","year":"2016","unstructured":"Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37:703\u201312.","journal-title":"Eur Heart J"},{"key":"1239_CR26","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jacc.2013.02.094","volume":"62","author":"F Maisano","year":"2013","unstructured":"Maisano F, Franzen O, Baldus S, Schafer U, Hausleiter J, Butter C, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62:1052\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"1239_CR27","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.echo.2015.04.005","volume":"28","author":"A Vitarelli","year":"2015","unstructured":"Vitarelli A, Mangieri E, Capotosto L, Tanzilli G, D'Angeli I, Viceconte N, et al. Assessment of biventricular function by three-dimensional speckle-tracking echocardiography in secondary mitral regurgitation after repair with the MitraClip system. J Am Soc Echocardiogr. 2015;28:1070\u201382.","journal-title":"J Am Soc Echocardiogr"},{"key":"1239_CR28","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"JF Obadia","year":"2018","unstructured":"\u2022 Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297\u2013306 This is the first of two recent trials on percutaneous repair of secondary mitral valve regurgitation. This trial showed no benefit of percutaneous repair in individuals with secondary MR.","journal-title":"N Engl J Med"},{"key":"1239_CR29","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"\u2022 Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307\u201318 This is the second of the two trials on percutaneous mitral valve repair. This trial showed that percutaneous mitral valve repair benefited a select group of individuals with secondary MR, and its results led to much debate as to which patient population would best benefit from percutaneous intervention.","journal-title":"N Engl J Med"},{"key":"1239_CR30","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","volume":"33","author":"A Vahanian","year":"2012","unstructured":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451\u201396.","journal-title":"Eur Heart J"},{"key":"1239_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","volume":"16","author":"WA Zoghbi","year":"2003","unstructured":"Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777\u2013802.","journal-title":"J Am Soc Echocardiogr"},{"key":"1239_CR32","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Packer M, Grayburn PA. Contrasting effects of pharmacological, procedural and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure. Circulation. 2019; This is a key review proposing a novel paradigm (i.e., proporionate and disproportionate mitral regurgitation) to help better understand the conflicting results of MITRA-FR and COAPT and which patients may benefit from percutaneous intervention.","DOI":"10.1161\/CIRCULATIONAHA.119.039612"},{"key":"1239_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","volume":"12","author":"PA Grayburn","year":"2019","unstructured":"Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging. 2019;12:353\u201362.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1239_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2018.07.021","volume":"205","author":"MJ Mack","year":"2018","unstructured":"Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, et al. Cardiovascular outcomes assessment of the MitraClip in patients with heart failure and secondary mitral regurgitation: design and rationale of the COAPT trial. Am Heart J. 2018;205:1\u201311.","journal-title":"Am Heart J"},{"key":"1239_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.15420\/icr.2018.40.1","volume":"14","author":"K Atianzar","year":"2019","unstructured":"Atianzar K, Zhang M, Newhart Z, Gafoor S. Why did COAPT win while MITRA-FR failed? Defining the appropriate patient population for MitraClip. Interv Cardiol. 2019;14:45\u20137.","journal-title":"Interv Cardiol"},{"key":"1239_CR36","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.jtcvs.2004.07.037","volume":"128","author":"EC McGee","year":"2004","unstructured":"McGee EC, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128:916\u201324.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1239_CR37","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.athoracsur.2003.09.090","volume":"77","author":"SK Bhudia","year":"2004","unstructured":"Bhudia SK, McCarthy PM, Smedira NG, Lam BK, Rajeswaran J, Blackstone EH. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg. 2004;77:1598\u2013606.","journal-title":"Ann Thorac Surg"},{"key":"1239_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2004.09.073","volume":"45","author":"AH Wu","year":"2005","unstructured":"Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1239_CR39","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1001\/jama.2011.1675","volume":"306","author":"MJ Mack","year":"2011","unstructured":"Mack MJ, Holmes DR Jr. Rational dispersion for the introduction of transcatheter valve therapy. JAMA. 2011;306:2149\u201350.","journal-title":"JAMA."},{"key":"1239_CR40","doi-asserted-by":"crossref","first-page":"e005216","DOI":"10.1161\/CIRCOUTCOMES.118.005216","volume":"12","author":"D Sukul","year":"2019","unstructured":"Sukul D, Allen J, Kumbhani DJ. Volume considerations for Transcatheter aortic valve replacement in Medicare\u2019s National Coverage Determination. Circ Cardiovasc Qual Outcomes. 2019;12:e005216.","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-019-1239-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T21:27:37Z","timestamp":1665091657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-019-1239-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1007\/s11886-019-1239-0","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"25 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Rina Mauricio and Dharam J. Kumbhani declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"150"}}